TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.43 0.27 (62.14%) 0.0 (-0.01%) 0.03 (4.27%) 0.0 (0.23%) 0.01 (1.71%) 0.42 (94.36%) -0.14 (-16.57%) -0.14 (-16.57%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.3635
Diluted P/E:
-0.3635
RSI(14) 1m:
62.77
VWAP:
0.7
RVol:

Events

Period Kind Movement Occurred At
10m Price decrease 10m 0.67 -0.03 (-3.69%) Oct 15 19:29
1m Price increase 1m 0.7 +0.01 (+1.17%) Oct 15 19:26
1m Price decrease 1m 0.69 -0.01 (-1.19%) Oct 15 19:20
1m Price increase 1m 0.7 +0.01 (+1.26%) Oct 15 19:11
1m Price increase 1m 0.71 +0.01 (+1.07%) Oct 15 19:03

Related News